dalteparin has been researched along with Biliary Tract Cancer in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Eguchi, H | 1 |
Kawamoto, K | 1 |
Tsujie, M | 1 |
Yukawa, M | 1 |
Kubota, M | 1 |
Asaoka, T | 1 |
Takeda, Y | 1 |
Noda, T | 1 |
Shimizu, J | 1 |
Nagano, H | 1 |
Doki, Y | 1 |
Mori, M | 1 |
Larsen, AC | 1 |
Brøndum Frøkjaer, J | 1 |
Wishwanath Iyer, V | 1 |
Vincents Fisker, R | 1 |
Sall, M | 1 |
Yilmaz, MK | 1 |
Kuno Møller, B | 1 |
Kristensen, SR | 1 |
Thorlacius-Ussing, O | 1 |
1 trial available for dalteparin and Biliary Tract Cancer
Article | Year |
---|---|
A Prospective, Multi-Center Phase I Study of Postoperative Enoxaparin Treatment in Patients Undergoing Curative Hepatobiliary-Pancreatic Surgery for Malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Biliary Tract Neoplasms; Chemoprevention; Digestive | 2020 |
1 other study available for dalteparin and Biliary Tract Cancer
Article | Year |
---|---|
Venous thrombosis in pancreaticobiliary tract cancer: outcome and prognostic factors.
Topics: Aged; Anticoagulants; Biliary Tract Neoplasms; Dalteparin; Female; Humans; Male; Middle Aged; Pancre | 2015 |